Aurinia Pharmaceuticals, Inc. (AUPH)
14.60
+0.16
(+1.11%)
USD |
NASDAQ |
Feb 09, 12:17
Aurinia Pharmaceuticals Price : 14.60 for Feb. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Oncolytics Biotech, Inc. | 0.8395 |
| Edesa Biotech, Inc. | 1.15 |
| Lexaria Bioscience Corp. | 0.74 |
| Xenon Pharmaceuticals, Inc. | 42.26 |
| ProMIS Neurosciences, Inc. | 13.06 |
Price Related Metrics
| PE Ratio | 26.02 |
| PS Ratio | 7.750 |
| Price to Book Value | 5.262 |
| Price to Free Cash Flow | 17.11 |
| Earnings Yield | 3.84% |
| Market Cap | 1.925B |
| Operating PE Ratio | 21.22 |
| Normalized PE Ratio | 22.74 |